000 02488 a2200769 4500
005 20250516041453.0
264 0 _c20110923
008 201109s 0 0 eng d
022 _a1520-4804
024 7 _a10.1021/jm2003552
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, Haishan
245 0 0 _aDiscovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cJul 2011
300 _a4694-720 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xchemical synthesis
650 0 4 _aBenzimidazoles
_xchemical synthesis
650 0 4 _aBiological Availability
650 0 4 _aCell Line, Tumor
650 0 4 _aDogs
650 0 4 _aDrug Screening Assays, Antitumor
650 0 4 _aFemale
650 0 4 _aHistone Deacetylase 1
_xantagonists & inhibitors
650 0 4 _aHistone Deacetylase Inhibitors
_xchemical synthesis
650 0 4 _aHumans
650 0 4 _aIsoenzymes
_xantagonists & inhibitors
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Nude
650 0 4 _aMicrosomes, Liver
_xmetabolism
650 0 4 _aNeoplasm Transplantation
650 0 4 _aQuantitative Structure-Activity Relationship
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aStereoisomerism
700 1 _aYu, Niefang
700 1 _aChen, Dizhong
700 1 _aLee, Ken Chi Lik
700 1 _aLye, Pek Ling
700 1 _aChang, Joyce Wei Wei
700 1 _aDeng, Weiping
700 1 _aNg, Melvin Chi Yeh
700 1 _aLu, Ting
700 1 _aKhoo, Mui Ling
700 1 _aPoulsen, Anders
700 1 _aSangthongpitag, Kanda
700 1 _aWu, Xiaofeng
700 1 _aHu, Changyong
700 1 _aGoh, Kee Chuan
700 1 _aWang, Xukun
700 1 _aFang, Lijuan
700 1 _aGoh, Kay Lin
700 1 _aKhng, Hwee Hoon
700 1 _aGoh, Siok Kun
700 1 _aYeo, Pauline
700 1 _aLiu, Xin
700 1 _aBonday, Zahid
700 1 _aWood, Jeanette M
700 1 _aDymock, Brian W
700 1 _aKantharaj, Ethirajulu
700 1 _aSun, Eric T
773 0 _tJournal of medicinal chemistry
_gvol. 54
_gno. 13
_gp. 4694-720
856 4 0 _uhttps://doi.org/10.1021/jm2003552
_zAvailable from publisher's website
999 _c20893638
_d20893638